Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results
- 12 April 2011
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 118 (8), 936-944
- https://doi.org/10.1111/j.1471-0528.2011.02952.x
Abstract
Please cite this paper as: Moss J, Cooper K, Khaund A, Murray L, Murray G, Wu O, Craig L, Lumsden M. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5‐year results. BJOG 2011;118:936–944. Objective To compare the long‐term results of uterine artery embolisation (UAE) with surgery for women with symptomatic uterine fibroids. Design Pragmatic, open, multicentre, randomised trial. Setting Twenty‐seven participating UK secondary care centres. Sample Women aged ≥18 years with symptomatic fibroids who were considered to justify surgical treatment. Methods In total, 157 women were randomised (in a 2:1 ratio): 106 to UAE and 51 to surgery (hysterectomy 42; myomectomy nine). Main outcome measures Quality of life at 5 years, as assessed by the Short Form General Health Survey (SF‐36). Secondary measures included complications, adverse events and the need for further intervention. Results There were no significant differences between groups in any of the eight components of the SF‐36 scores at 5 years (minimum P = 0.45). Symptom score reduction and patient satisfaction with either treatment was very high, with no group difference. Rates of adverse events were similar in both groups (19% embolization and 25% surgery; P = 0.40). The 5‐year intervention rate for treatment failure or complications was 32% (UAE arm) and 4% (surgery arm), respectively. The initial cost benefit of UAE over surgery at 12 months was substantially reduced because of subsequent interventions, with treatments being cost neutral at 5 years. Conclusions We have found that UAE is a satisfactory alternative to surgery for fibroids. The less invasive nature of UAE needs to be balanced against the need for re‐intervention in almost a third of patients. The choice should lie with the informed patient.Keywords
This publication has 15 references indexed in Scilit:
- Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trialAmerican Journal of Obstetrics and Gynecology, 2010
- The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroidsBJOG: An International Journal of Obstetrics and Gynaecology, 2010
- Midterm Clinical and First Reproductive Results of a Randomized Controlled Trial Comparing Uterine Fibroid Embolization and MyomectomyCardioVascular and Interventional Radiology, 2007
- A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium‐term safety and efficacyBJOG: An International Journal of Obstetrics and Gynaecology, 2007
- Uterine-Artery Embolization versus Surgery for Symptomatic Uterine FibroidsThe New England Journal of Medicine, 2007
- Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri- and postprocedural results from a randomized controlled trialAmerican Journal of Obstetrics and Gynecology, 2005
- Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utilityHealth Economics, 2004
- Society of Interventional Radiology Clinical Practice GuidelinesJournal of Vascular and Interventional Radiology, 2003
- Uterine Fibroids: Uterine Artery Embolization versus Abdominal Hysterectomy for Treatment—A Prospective, Randomized, and Controlled Clinical TrialRadiology, 2003
- Arterial embolisation to treat uterine myomataThe Lancet, 1995